Northfield Bancorp, Inc. (NFBK) At $16.22 Forms Bottom; 1 Analysts Are Bullish Chemed (CHE) Last Week

February 19, 2018 - By Shannon Black

Northfield Bancorp, Inc. (NFBK) formed multiple bottom with $15.57 target or 4.00% below today’s $16.22 share price. Northfield Bancorp, Inc. (NFBK) has $792.25 million valuation. The stock increased 1.19% or $0.19 during the last trading session, reaching $16.22. About 195,110 shares traded or 75.26% up from the average. Northfield Bancorp, Inc. (NASDAQ:Staten Island, NY) has 0.00% since February 19, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 3 analysts covering Chemed (NYSE:CHE), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Chemed had 17 analyst reports since July 27, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Sector Perform” rating in Tuesday, November 1 report. The rating was maintained by KeyBanc Capital Markets on Thursday, October 26 with “Hold”. RBC Capital Markets maintained the shares of CHE in report on Tuesday, May 30 with “Hold” rating. As per Monday, July 27, the company rating was maintained by RBC Capital Markets. The stock of Chemed Corporation (NYSE:CHE) has “Hold” rating given on Wednesday, July 5 by RBC Capital Markets. The stock has “Outperform” rating by Oppenheimer on Monday, October 26. RBC Capital Markets maintained the stock with “Hold” rating in Sunday, July 30 report. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) on Friday, February 16 with “Hold” rating. The stock of Chemed Corporation (NYSE:CHE) earned “Outperform” rating by Oppenheimer on Tuesday, September 22. The rating was maintained by RBC Capital Markets with “Sector Perform” on Monday, May 2. See Chemed Corporation (NYSE:CHE) latest ratings:

16/02/2018 Broker: RBC Capital Markets Rating: Hold New Target: $258.0 Maintain
27/10/2017 Broker: Oppenheimer Rating: Outperform Old Target: $220 New Target: $225 Maintain
26/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
02/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $209.0 Maintain
01/09/2017 Broker: RBC Capital Markets Rating: Hold New Target: $209.0 Maintain
28/08/2017 Broker: KeyBanc Capital Markets Rating: Sector Weight Initiates Coverage On

Chemed Corporation provides hospice and palliative care services in the United States. The company has market cap of $4.06 billion. It operates through two divisions, VITAS and Roto-Rooter. It has a 56.11 P/E ratio. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.14, from 1.18 in 2017Q2. It worsened, as 21 investors sold Chemed Corporation shares while 80 reduced holdings. 29 funds opened positions while 76 raised stakes. 15.40 million shares or 0.81% more from 15.27 million shares in 2017Q2 were reported. Clark Cap Mngmt Gru Inc Inc invested 0.06% in Chemed Corporation (NYSE:CHE). Great West Life Assurance Can holds 21,743 shares. Jefferies Grp Limited Liability Corp reported 0.01% of its portfolio in Chemed Corporation (NYSE:CHE). Sei Invs accumulated 16,913 shares or 0.01% of the stock. 1,037 are held by Campbell Company Invest Adviser Limited Company. Connecticut-based Aqr Capital Management Ltd Liability Com has invested 0% in Chemed Corporation (NYSE:CHE). First Citizens Bancorp accumulated 0.04% or 1,344 shares. Public Sector Pension Board invested 0.01% of its portfolio in Chemed Corporation (NYSE:CHE). Bessemer Gp holds 15,267 shares or 0.01% of its portfolio. Riverbridge Partners Ltd Com invested in 565,450 shares or 2.25% of the stock. Virginia Retirement Et Al has invested 0.03% in Chemed Corporation (NYSE:CHE). Carroll Financial Associates invested 0% of its portfolio in Chemed Corporation (NYSE:CHE). State Street Corp stated it has 0.01% of its portfolio in Chemed Corporation (NYSE:CHE). Blackrock Inc invested 0.02% in Chemed Corporation (NYSE:CHE). State Of Alaska Department Of Revenue, a Alaska-based fund reported 3,189 shares.

The stock decreased 0.28% or $0.72 during the last trading session, reaching $254.56. About 162,123 shares traded or 63.21% up from the average. Chemed Corporation (NYSE:CHE) has risen 54.48% since February 19, 2017 and is uptrending. It has outperformed by 37.78% the S&P500.

Since September 1, 2017, it had 0 insider purchases, and 5 insider sales for $2.82 million activity. Dallob Naomi C sold $166,568 worth of stock. On Monday, October 2 the insider GRACE PATRICK P sold $100,740. $2.23M worth of stock was sold by MCNAMARA KEVIN J on Monday, October 30. LEE SPENCER S sold $197,460 worth of Chemed Corporation (NYSE:CHE) on Friday, September 1. The insider SAUNDERS DONALD E sold $117,485.